ADVANCED BILE DUCT CARCINOMA
Clinical trials for ADVANCED BILE DUCT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILE DUCT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILE DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase trial tests a new drug (BAY 1895344) combined with standard chemotherapy in people with advanced solid tumors, especially bladder cancer. The goal is to find the safest dose and see how well the combination works. About 74 adults with cancers like lung, bladder, …
Matched conditions: ADVANCED BILE DUCT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug combo aims to boost Radiation's punch against tough GI cancers
Symptom relief OngoingThis early-phase study tested an oral drug called ropidoxuridine (IPdR) in 19 people with advanced gastrointestinal cancers that could not be cured. The goal was to find the safest dose and see if the drug could make tumor cells more sensitive to radiation therapy. The study focu…
Matched conditions: ADVANCED BILE DUCT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 17, 2026 04:15 UTC